I. Introduction
With the aid of medical imaging technologies, illness identification and diagnosis have become simpler. The global community has recently been impacted by the COVID-19 pandemic, regarded as the biggest public health emergency the world has ever seen [1]. Covid-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2); recently, Covid-19 has been shown to provoke pneumonia, among other diseases [2]. Such diseases may be present in one or both lungs, which can be diagnosed using imaging exams [3]. Examples of such imaging exams include chest X-ray (CXR), which is often helpful because it is cheap, fast, widespread, and uses less radiation. Even though typical CXR images may help early screening of suspected cases, the images of various lung infections are similar and often overlap with other inflammatory lung diseases. However, manual image analysis is tedious and sometimes susceptible to inter and intra-variability, depending on the observer [4]. For this reason, it is difficult for radiologists to distinguish viral pneumonia, tuberculosis, Covid-19, lung cancer, and other lung-related diseases.